Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

5.010 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Provides Business Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
U.S. Department of Justice Declines Prosecution 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
Going concern qualification is removed as a result of the $150 million new financing transaction announced last week 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
Proceeds to be used for debt paydown 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
From Lifecore Biomedical, Inc.
Via GlobeNewswire
News headline image
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
$5 million PIPE supports near-term capital needs to meet equipment milestones 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.